Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Haematologica|February 13, 2008
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapyNigel Russell, Rolf Mesters, Joerg Schubert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2014
Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow TransplantationEdward Truelove, Christopher Fox, Stephen Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trialsClaire H Seedhouse, Martin Grundy, Paul White, et al.
British Journal of Haematology|May 7, 2021
A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trialMike Dennis, Alan Burnett, Robert Hills, et al.
Haematologica|August 24, 2014
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failureEmma Das-Gupta, Hildegard Greinix, Ryan Jacobs, et al.
British Journal of Haematology|March 18, 2009
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trialAlan K Burnett, Donald Milligan, Anthony Goldstone, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2011
Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation RegistryGordon Cook, Effie Liakopoulou, Rachel Pearce, et al.
Haematologica|September 18, 2012
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trialNigel Russell, Kenny Douglas, Anthony D Ho, et al.
Pageof 12